Angiotensin‐converting enzyme (ACE) inhibitors and angiotensin II receptor blockers
(ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action …

Objective ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are widely
prescribed in patients with high cardiovascular (CV) risk. However, whether both classes …

Abstract Background Angiotensin receptor blockers (ARBs) are commonly used as a
treatment for many cardiovascular diseases, but their safety has been called into question …

BACKGROUND Angiotensin II receptor blockers (ARBs) and angiotensin‐converting
enzyme inhibitors (ACEIs) block distinct components of the renin‐angiotensin system …

Arterial hypertension is a major risk factor for cardiovascular disease. More importantly,
given its worldwide prevalence, hypertension is the single biggest contributor to global …

Context. Whether angiotensin converting‐enzyme inhibitors (ACEI) and angiotensin‐
receptor blockers (ARB) are useful in high risk patients without heart failure is unclear. We …

Background There are few reviews comparing the long-term outcomes of the use of
angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in a …

Angiotensin receptor blockers (ARBs) are the most commonly used among blood pressure-
lowering drugs worldwide, despite the absence of sound evidence of effectiveness in large …

Previously, management of hypertension has concentrated on lowering elevated blood
pressure. However, the target has shifted to reducing absolute cardiovascular (CV) risk. It is …

J Clin Hypertens (Greenwich). 2012; 14: 407–414.© 2012 Wiley Periodicals, Inc. Important
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …